Assa Abloy Inc.

Assa Abloy Inc. is an entity related to Assa Abloy AB, a global leader in access solutions headquartered in Stockholm, Sweden, and founded in 1994. The parent company, Assa Abloy AB, is publicly traded on Nasdaq Stockholm under the ticker ASSA B. As of 2023-2025, the Assa Abloy Group employs approximately 61,000 to 64,460 people globally and reported annual sales around SEK 140.7 billion to SEK 152.4 billion (approximately $15.9 billion in trailing 12-month revenue as of March 2026). Its market capitalization was $38.1 billion as of June 2026.

Assa Abloy operates across more than 70 countries, manufacturing and supplying a comprehensive range of products and services related to locks, doors, gates, and entrance automation. Their offerings include mechanical and electromechanical locks, electronic access control systems, digital access solutions, panic escape devices, padlocks, door closers, and security doors. The company serves diverse sectors such as residential, commercial, government, healthcare, education, hospitality, and industrial facilities. Major brands within the Assa Abloy portfolio include Yale, Kwikset, Medeco, Mul-T-Lock, and Sargent.

Regarding patent litigation, Assa Abloy Inc. has a limited footprint in the provided database, appearing as a plaintiff in one case and as a defendant in zero cases. The sole tracked case, HID Global Corp. et al. v. CPC Patent Technologies Pty Ltd., was initiated on June 13, 2022, before the Patent Trial and Appeal Board (PTAB). This posture suggests that Assa Abloy Inc. acts defensively to challenge patents rather than actively asserting its own portfolio as a plaintiff in district court litigation.

The single tracked case at the PTAB, HID Global Corp. et al. v. CPC Patent Technologies Pty Ltd., indicates Assa Abloy's involvement in a patent challenge, likely an inter partes review (IPR), against a third-party entity, CPC Patent Technologies Pty Ltd. This suggests Assa Abloy (via its subsidiary HID Global Corp.) is engaging in administrative proceedings to invalidate patents, which is a common strategy for operating companies to clear the path for their products or defend against potential infringement claims.